As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins.